Beyond Phylogeny: Evolutionary analysis of a mosaic pathogen - PowerPoint PPT Presentation

1 / 28
About This Presentation
Title:

Beyond Phylogeny: Evolutionary analysis of a mosaic pathogen

Description:

17- Oyster (USA) 49- Environment (Germany) 44- Environment (Germany) ... 22- Oyster (USA) 8- Human (61), healthy fish (1) (Israel) 45-Environment (Germany) ... – PowerPoint PPT presentation

Number of Views:27
Avg rating:3.0/5.0
Slides: 29
Provided by: rosalind9
Category:

less

Transcript and Presenter's Notes

Title: Beyond Phylogeny: Evolutionary analysis of a mosaic pathogen


1
Beyond Phylogeny Evolutionary analysis of a
mosaic pathogen
  • Dr Rosalind Harding
  • Departments of Zoology and Statistics, Oxford
    University,UK

2
Research Collaborators
  • Naiel Bisharat
  • Dept of Epidemiology and Preventative Medicine,
    Tel Aviv University, Israel
  • Derrick Crook
  • Nuffield Dept of Clinical Laboratory Sciences,
    John Radcliffe Hospital, University of Oxford, UK
  • Martin Maiden
  • Dept of Zoology, University of Oxford

Bisharat et al. (2005) Hybrid Vibrio vulnificus
Emerg Infect Dis 1130-35
3
Population Genetics
  • Interplay of micro-evolutionary processes
  • Mutation and recombination
  • Population structure and demography
  • Natural selection
  • Questions and strategy concern
  • Understanding steady-state patterns of diversity
  • Learning about ancestral history (genealogy)
  • Understanding dynamics emergence of new strains
  • Major technical problem
  • Trees dont show recombination events

4
Vibrio vulnificus
  • Globally wide-spread inhabitant of marine and
    estuarine environments
  • Dangerous waterborne pathogen case fatality rate
    for V. vulnificus septicemia may reach 50
  • Typically, cases of V. vulnificus infection are
    sporadic
  • Human infection acquired through eating
    contaminated raw or undercooked sea food, or via
    contamination of wounds by seawater or marine
    animals

5
Disease Outbreak in Israel
  • Major outbreak of systemic V. vulnificus
    infection among fish market workers and fish
    consumers
  • Epidemiology
  • 1995 first case
  • 1996 32 patients
  • 1997 30 patients
  • all handled fresh Tilapia fish cultivated in
    inland fish farms
  • 1998 marketing policy changed to prevent sale
    handling of live Tilapia fish
  • New biotype identified
  • Distinctive biochemistry, eg salicin-negative,
    lactose-negative (5 atypical characteristics for
    the species).

6
Severe soft tissue infections/ Necrotizing
fasciitis
7
V. vulnificus diversity
  • Biotype 1 sampled from environment, healthy
    fish, shellfish etc associated with sporadic
    human infection
  • Biotype 2 associated with disease in eels
  • Biotype 3 new cause of human disease outbreak in
    Israel.
  • Where did Biotype 3 come from?

Biotypes have been defined based on biochemical
tests of phenotype.
8
Initial genetic analysis
  • MLST multi-locus sequence typing
  • Sequences of fragments of housekeeping genes
    (dN/dS ratios lt 1.0)
  • 10 genes, 5 from each of the two chromosomes,
    each fragment 400 bp
  • Concatenated sequence of 4,326 bp defines
    sequence types (STs)
  • Isolates
  • Biotype 1 n82 isolates (39 from human disease,
    43 from environment
  • Biotype 2 n15 isolates (13 from eels)
  • Biotype 3 n61 isolates (60 from human disease,
    1 from fish-pond water)

9
UPGMA tree of concatenated sequences of 10 genes
two major groups I II, plus ST8
I
ST8Biotype 3
All Biotype 3 isolates were identical at level of
MLST resolution.
10
Genetic differentiation into two populations is
not explained by geographic location of isolates
Output from STRUCTURE analysis, assuming K 3
populations
11
Genetic differentiation into two populations is
not explained by biotype distribution.
Biotype 1 occurs in both populations
However, Biotype 3 does have a distinctive
intermediate genetic identity between the
populations.
Biotype 3
Output from STRUCTURE analysis, assuming K 3
populations
12
Two populations different disease associations
Population B is associated with disease in humans
Population A is associated with eel disease
Output from STRUCTURE analysis, assuming K 3
populations
UPGMA Group II
UPGMA Group I
13
Biotype 3 is a hybrid between parents from
Population A and Population B
Inferred ancestry
14
Biotype 3 is a mosaic genome
A
I
II
B
15
Clonal expansion of Biotype 3
Maynard Smith, J et al (2000) BioEssays
221115-1122
Disease outbreak clones emerge from a background
of low frequency variation connected by mutation
and recombination.
16
Progress summary
  • The disease outbreak in Israel (Biotype 3) was
    caused by a clonal expansion of Sequence Type 8
  • ST 8 is a mosaic sequence created by
    recombination between parents from Populations A
    and B
  • Next questions
  • How much recombination?
  • How did the genetic differentiation between
    Populations A and B arise?
  • Population A UPGMA Group I Eel disease
    associated
  • Population B UPGMA Group II Human disease
    associated

17
Splits graph of concatenated sequences from 10
genes
Cluster I Population A Association with eel
disease (biotype 2)
ST8 Biotype 3
Cluster II Population B Association with human
disease
18
Recombination exchange between groups I II is
rare
Splits graph of allelic sequences from glp gene
I
ST8 (Biotype 3) has a glp allele from Population
B/group II
II
Alleles 12 and 38 from Cluster II STs are more
closely related to Cluster I
19
Recombination rates within genes within groups
are high
  • Evidence of recombination from Beagle
    www.stats.ox.ac.uk/lyngsoe/beagle

Ancestral history is not as simple as a tree.
Minimum of 9 recombination events
Splits graph of alleles from dtdS gene
II
I
20
Polymorphism for a complex trait?
Next Question.
  • Is the genetic differentiation related to
    pathogenicity phenotype?
  • higher odds for causing either human or eel
    disease

21
Isolation in a metapopulation?
Is the genetic differentiation caused by
isolation between populations?
22
Any clues from diversity in individual genes?
  • If polymorphism, perhaps expect differentiation
    to localise to one or a subset of genes?
  • If differentiation is due to isolation between
    populations, expect all genes to show the same
    patterns.

23
UPGMA group I (Population A)
Biotype 3
In Biotype 3, genes 1, 2, 4, 10 are from group
II, i.e. human disease associated.
UPGMA group II (Population B)
24
The same split is preserved across genes 1, 2, 4
10
1. Large chromosome glp
4. Large chromosome metG
2. Large chromosome gyrB
10. Small chromosome tnaA
25
But the same split is also preserved across the
other 6 genes, e.g.
5. Large chromosome purM
8. Small chromosome pntA
9. Small chromosome pyrC
6. Small chromosome dtdS
26
Conclusions
  • Differentiation between populations is evident
    across all 10 genes. Recombination exchange
    between populations is rare across all genes.
  • Within populations Large numbers of alleles
    related through recombination as well as mutation
    history
  • Isolation by distance? Polymorphism?
  • Recombination is key to generating diversity in
    Vibrio vulnificus

27
(No Transcript)
28
  • Meta-population structure
  • Old population diversity generated by mutation
    and recombination is sustained.
  • Differentiation is shaped by isolation outbreaks
    emerge as new recombinants
  • Clonal Expansion
  • In expansions of clonal complexes, new mutations
    are evident before recombination. (Linkage
    disequilibrium due to selective sweep.)
  • Differentiation is shaped by selection clonal
    complexes emerge as new adaptations
Write a Comment
User Comments (0)
About PowerShow.com